Open AccessThe in vitro and in vivo anti‐tumor effect of KO‐202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer
Author(s) -
Oh Miyun,
Lee JeongYeon,
Shin DongHui,
Park JiHye,
Oian Tingting,
Kim HyunJun,
Cho SungDae,
Oh SeungHyun,
Min Young Ki,
Kong Gu
Publication year - 2011
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2011.01838.x
Subject(s) - breast cancer , medicine , in vivo , oncology , cancer , cancer research , biology , microbiology and biotechnology